GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CrystalGenomics Invites Co Ltd (XKRX:083790) » Definitions » EV-to-EBITDA

CrystalGenomics Invites Co (XKRX:083790) EV-to-EBITDA : -3.43 (As of Dec. 15, 2024)


View and export this data going back to 2006. Start your Free Trial

What is CrystalGenomics Invites Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, CrystalGenomics Invites Co's enterprise value is ₩191,605 Mil. CrystalGenomics Invites Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was ₩-55,863 Mil. Therefore, CrystalGenomics Invites Co's EV-to-EBITDA for today is -3.43.

The historical rank and industry rank for CrystalGenomics Invites Co's EV-to-EBITDA or its related term are showing as below:

XKRX:083790' s EV-to-EBITDA Range Over the Past 10 Years
Min: -11773.7   Med: -25.14   Max: 1245.23
Current: -3.43

During the past 13 years, the highest EV-to-EBITDA of CrystalGenomics Invites Co was 1245.23. The lowest was -11773.70. And the median was -25.14.

XKRX:083790's EV-to-EBITDA is ranked worse than
100% of 452 companies
in the Biotechnology industry
Industry Median: 9.27 vs XKRX:083790: -3.43

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-12-15), CrystalGenomics Invites Co's stock price is ₩2490.00. CrystalGenomics Invites Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₩-801.000. Therefore, CrystalGenomics Invites Co's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


CrystalGenomics Invites Co EV-to-EBITDA Historical Data

The historical data trend for CrystalGenomics Invites Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CrystalGenomics Invites Co EV-to-EBITDA Chart

CrystalGenomics Invites Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -31.19 -348.28 -39.94 -12.89 -4.21

CrystalGenomics Invites Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.13 -4.21 -6.01 -6.80 -3.37

Competitive Comparison of CrystalGenomics Invites Co's EV-to-EBITDA

For the Biotechnology subindustry, CrystalGenomics Invites Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CrystalGenomics Invites Co's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, CrystalGenomics Invites Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where CrystalGenomics Invites Co's EV-to-EBITDA falls into.



CrystalGenomics Invites Co EV-to-EBITDA Calculation

CrystalGenomics Invites Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=191605.231/-55862.533
=-3.43

CrystalGenomics Invites Co's current Enterprise Value is ₩191,605 Mil.
CrystalGenomics Invites Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-55,863 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CrystalGenomics Invites Co  (XKRX:083790) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

CrystalGenomics Invites Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2490.00/-801.000
=At Loss

CrystalGenomics Invites Co's share price for today is ₩2490.00.
CrystalGenomics Invites Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-801.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


CrystalGenomics Invites Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of CrystalGenomics Invites Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


CrystalGenomics Invites Co Business Description

Traded in Other Exchanges
N/A
Address
5F, A-dong, Korea Bio Park, 694-1, Sampyeong-dong, Bundang-gu, Seongnam-si, Gyeonggi, KOR, 463-400
CrystalGenomics Invites Co Ltd Formerly CrystalGenomics Inc is one of the leading biopharmaceutical company in Korea. The company is mainly engaged in the research and development and new drug development. It develops innovative new drug development projects such as eradication antibiotics and molecular targeted anticancer drugs. It focuses on arthritic medicines and antibiotics which kill resistant bacteria. It also offers medicines for cancer, obesity, asthma, and diabetes.

CrystalGenomics Invites Co Headlines

No Headlines